| Match | Type | Why |
|---|
| Advanced or metastatic pancreatic cancer: molecular targeted therapies. | Academic Article |
Why?
|
| Alli, Elizabeth | Person |
Why?
|
| Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. | Academic Article |
Why?
|
| Emerging therapeutic targets and agents for glioblastoma therapy--part II. | Academic Article |
Why?
|
| Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant. | Academic Article |
Why?
|
| Epigenetic coordination of acute systemic inflammation: potential therapeutic targets. | Academic Article |
Why?
|
| Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. | Academic Article |
Why?
|
| Giving AXL the axe: targeting AXL in human malignancy. | Academic Article |
Why?
|
| Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis. | Academic Article |
Why?
|
| Medication-based versus target-based lipid management. | Academic Article |
Why?
|
| Melanocortin 1 Receptor-Targeted a-Particle Therapy for Metastatic Uveal Melanoma. | Academic Article |
Why?
|
| Molecular subtyping of brain metastases and implications for therapy. | Academic Article |
Why?
|
| Molecular targeted a-particle therapy for oncologic applications. | Academic Article |
Why?
|
| New and Emerging Systemic Treatments for Atopic Dermatitis. | Academic Article |
Why?
|
| Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. | Academic Article |
Why?
|